Treace Medical Concepts Files 8-K: Operations, Officers, and Reg FD
Ticker: TMCI · Form: 8-K · Filed: 2026-04-09T07:00:09-04:00
Sentiment: neutral
Topics: operations, officer-departure, financial-condition, regulation-fd
Related Tickers: TMCI
TL;DR
TREACE MEDICAL CONCEPTS (TMCI) filed an 8-K on 4/9/26 covering Q1 results, officer changes, and Reg FD.
AI Summary
Treace Medical Concepts, Inc. filed an 8-K on April 9, 2026, reporting on results of operations and financial condition as of April 8, 2026. The filing also disclosed departures of certain officers, director elections, and compensatory arrangements. Additionally, it included a Regulation FD disclosure.
Why It Matters
This 8-K filing provides crucial updates on Treace Medical Concepts' financial performance and significant corporate governance changes, impacting investor understanding of the company's current status.
Risk Assessment
Risk Level: medium — The filing includes updates on financial results and officer departures, which can introduce uncertainty and affect investor confidence.
Key Players & Entities
- Treace Medical Concepts, Inc. (company) — Filer of the 8-K
- 0001630627 (company) — CIK number for Treace Medical Concepts, Inc.
- 2026-04-09 (date) — Filing date of the 8-K
- 2026-04-08 (date) — Period of report for the 8-K
FAQ
What specific financial results were reported for the period ending April 8, 2026?
The 8-K filing indicates Item 2.02 pertains to Results of Operations and Financial Condition, but the specific financial figures are not detailed in the provided filing summary.
Which officers departed from Treace Medical Concepts, Inc.?
The filing notes Item 5.02 covers the departure of directors or certain officers, but the names of the specific individuals are not listed in the provided summary.
What was the nature of the Regulation FD disclosure?
Item 7.01 of the 8-K filing is for Regulation FD Disclosure, however, the content of this disclosure is not specified in the provided document details.
When was the 8-K filing accepted by the SEC?
The 8-K filing was accepted on 2026-04-09 at 07:00:09.
What is the primary business of Treace Medical Concepts, Inc. according to the filing?
Treace Medical Concepts, Inc. is listed under SIC code 3841, which corresponds to Surgical & Medical Instruments & Apparatus.
From the Filing
EDGAR Filing Documents for 0001630627-26-000010 This page uses Javascript. Your browser either doesn't support Javascript or you have it turned off. To see this page as it is meant to appear please use a Javascript enabled browser. SEC.gov EDGAR Latest Filings Filings search tools Filing Detail SEC Home » Company Search » Current Page Form 8-K - Current report: SEC Accession No. 0001630627-26-000010 Filing Date 2026-04-09 Accepted 2026-04-09 07:00:09 Documents 9 Period of Report 2026-04-08 Items Item 2.02: Results of Operations and Financial Condition Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 7.01: Regulation FD Disclosure Interactive Data Document Format Files Seq Description Document Type Size 1 8-K tmci-20260408.htm iXBRL 8-K 69902 Complete submission text file 0001630627-26-000010.txt 181392 Data Files Seq Description Document Type Size 2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT tmci-20260408.xsd EX-101.SCH 28273 12 EXTRACTED XBRL INSTANCE DOCUMENT tmci-20260408_htm.xml XML 4536 Mailing Address 100 PALMETTO PARK PLACE PONTE VEDRA FL 32081 Business Address 100 PALMETTO PARK PLACE PONTE VEDRA FL 32081 (904) 373-5940 TREACE MEDICAL CONCEPTS, INC. (Filer) CIK : 0001630627 (see all company filings) EIN. : 471052611 | State of Incorp.: FL | Fiscal Year End: 1231 Type: 8-K | Act: 34 | File No.: 001-40355 | Film No.: 26849783 SIC : 3841 Surgical & Medical Instruments & Apparatus (CF Office: 08 Industrial Applications and Services)